3,0
28 apr 2014
Dipendente attuale, più di 5 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Great idea. Orphan drugs to meet unmet needs of patients with rare diseases and humanitarian program.
Svantaggi
No documented processes,acknowleged bad practices continue for 5+ years, management promoted based on years of service rather than merit, terrible work/life balance, stagnant career growth since Sanofi acquisition.